Involvement of TRP channels in the signal transduction of bradykinin in human osteoblasts

Bradykinin (BK), a mediator of pain and inflammation, is involved in bone metabolism. We have previously reported that BK increased the synthesis of interleukin-6 and prostaglandin E₂ via phosphorylation of ERK1/2 in human osteoblasts, SaM-1. In the present study, we investigated the signal transduction pathway of BK focusing on intracellular Ca²⁺ kinetics in SaM-1 cells. Bath-applied BK increased intracellular Ca²⁺ concentration through the activation of B₂ receptors. Removal of extracellular Ca²⁺ attenuated the effects of BK. Additionally, thapsigargin, endoplasmic reticulum Ca²⁺ pump inhibitor, completely inhibited BK-induced increase of intracellular Ca²⁺. These results suggested that bath-applied BK activated store-operated Ca²⁺ channels (SOCCs) following Ca²⁺ store depletion via B₂ receptor. Although the molecular components of SOCCs have yet to be conclusively identified in all cell types, recent studies demonstrated that transient receptor potential canonical (TRPC) channels are candidates for them. TRPC1, TRPC3, TRPC4 and TRPC6 were expressed in SaM-1 cells and inhibitors of TRP channel, 2-aminoethoxydiphenyl borate, GdCl₃, LaCl₃ and flufenamic acid, inhibited the effects of BK. These findings suggested that BK activated SOCCs and induced Ca²⁺ influx via B₂ receptor in human osteoblasts. Molecular components of the SOCCs are suggested to be TRPC channels.